ClinVar Miner

Submissions for variant NM_000251.2(MSH2):c.376G>A (p.Gly126Ser) (rs767371843)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000166502 SCV000217301 uncertain significance Hereditary cancer-predisposing syndrome 2019-01-07 criteria provided, single submitter clinical testing Insufficient or conflicting evidence;Co-occurence with mutation in same gene (phase unknown)
Invitae RCV000199020 SCV000254419 uncertain significance Hereditary nonpolyposis colorectal neoplasms 2019-12-31 criteria provided, single submitter clinical testing This sequence change replaces glycine with serine at codon 126 of the MSH2 protein (p.Gly126Ser). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs767371843, ExAC 0.001%). This variant has been reported in individuals affected with Lynch syndrome-associated tumors (PMID: 24278394, 28449805). However, one of these individuals also carried another variant in the MSH2 gene (PMID: 24278394). ClinVar contains an entry for this variant (Variation ID: 186849). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Fulgent Genetics,Fulgent Genetics RCV000515190 SCV000611401 uncertain significance Lynch syndrome I; Turcot syndrome; Muir-Torré syndrome 2017-05-23 criteria provided, single submitter clinical testing
Color RCV000166502 SCV001349879 uncertain significance Hereditary cancer-predisposing syndrome 2019-06-27 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.